SingleC-9 Binding Agents

The present invention relates to agents capable of binding sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) and their use in the treatment of cell proliferation and differentiation disorders. Furthermore, the present invention provides associated pharmaceutical formulations and methods.

Patents:
US 20,110,104,149   [MORE INFO]

Inventor(s): CROCKER PAUL RICHARD [GB]; BIEDERMANN BJOERN [GB]; BOWEN DAVID [GB]

Type of Offer: Sale



« More Pharmaceutical Patents

---